🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

iTeos Therapeutics, Inc.

iTeos Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

inupadenant, EOS-448

Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.

Tags: biopharmaceutical, clinical trials, immuno-oncology, therapeutics

Website

About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About | About | About | About

Symbol: ITOS

Recent Price: $7.29

Industry: Biotechnology

CEO: Dr. Michel Detheux Ph.D.

Sector: Healthcare

Employees: 157

Address: 321 Arsenal Street, Cambridge, MA 02472-5710

Phone: 339 217 0161

Leadership

  • Michel DETHEUX, President, Chief Executive Officer
  • Matt CALL, Chief Operating Officer
  • Matthew GALL, Chief Financial Officer
  • Yvonne MCGRATH, Chief Scientific Officer
  • David Feltquate, Chief Medical Officer
  • Philippe BRANTEGEM, Executive Vice President of Human Resources
  • Adi OSOVSKY, Executive Vice President of Legal
  • David HALLAL, Chair of the Board
  • Aaron DAVIS,
  • Jill DESIMONE,
  • David LEE,
  • Tim VAN HAUWERMEIREN,
  • Tony HO,
  • Robert IANNONE,
  • Ann RHOADS,

Last updated: 2024-12-31